Drug toxicity and cost as barriers to community participation in HAT control in the Democratic Republic of Congo

scientific article published on February 2007

Drug toxicity and cost as barriers to community participation in HAT control in the Democratic Republic of Congo is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1365-3156.2006.01768.X
P698PubMed publication ID17300638
P5875ResearchGate publication ID6504090

P50authorMarleen BoelaertQ28817180
P2093author name stringJ Robays
P Lutumba
P Van der Stuyft
P Lefèvre
S Lubanza
V Kande Betu Ku Mesu
P2860cites workThe lessons of user fee experience in AfricaQ33580186
Trypanosomiasis control, Democratic Republic of Congo, 1993-2003Q35847379
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectDemocratic Republic of the CongoQ974
P304page(s)290-298
P577publication date2007-02-01
P1433published inTropical Medicine and International HealthQ15765747
P1476titleDrug toxicity and cost as barriers to community participation in HAT control in the Democratic Republic of Congo
P478volume12

Reverse relations

cites work (P2860)
Q33528943A CATT negative result after treatment for human African trypanosomiasis is no indication for cure
Q35126629A mixed methods study of a health worker training intervention to increase syndromic referral for gambiense human African trypanosomiasis in South Sudan.
Q26825682Contemporary and emerging strategies for eliminating human African trypanosomiasis due to Trypanosoma brucei gambiense: review
Q33834052Diagnostic accuracy of PCR in gambiense sleeping sickness diagnosis, staging and post-treatment follow-up: a 2-year longitudinal study
Q34305891Early prediction of treatment efficacy in second-stage gambiense human African trypanosomiasis
Q39401301Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola
Q58842233Ethical Considerations for Global Health Decision-Making: Justice-Enhanced Cost-Effectiveness Analysis of New Technologies for
Q35345427From health advice to taboo: community perspectives on the treatment of sleeping sickness in the Democratic Republic of Congo, a qualitative study
Q39052722Health care-seeking behaviour and diagnostic delays for Human African Trypanosomiasis in the Democratic Republic of the Congo
Q29056943Human African Trypanosomiasis in the Democratic Republic of the Congo: A Looming Emergency?
Q37034565Human African trypanosomiasis in Côte d'Ivoire and Burkina Faso: optimization of epidemiologic surveillance strategies
Q37302722Human African trypanosomiasis in a rural community, Democratic Republic of Congo
Q34500882Human african trypanosomiasis diagnosis in first-line health services of endemic countries, a systematic review
Q56888277Integrating innovations: a qualitative analysis of referral non-completion among rapid diagnostic test-positive patients in Uganda's human African trypanosomiasis elimination programme
Q64296317Integration of Human African Trypanosomiasis Control Activities into Primary Health Services in the Democratic Republic of the Congo: A Qualitative Study of Stakeholder Perceptions
Q57061698Knowledge, attitudes and practices about human African trypanosomiasis and their implications in designing intervention strategies for Yei county, South Sudan
Q56504613Monitoring the use of nifurtimox-eflornithine combination therapy (NECT) in the treatment of second stage gambiense human African trypanosomiasis
Q27004352Persistent digestive disorders in the tropics: causative infectious pathogens and reference diagnostic tests
Q28555206Predicting the Impact of Intervention Strategies for Sleeping Sickness in Two High-Endemicity Health Zones of the Democratic Republic of Congo
Q36198356Prevalence and under-detection of gambiense human African trypanosomiasis during mass screening sessions in Uganda and Sudan
Q33745212Quantifying the burden of rhodesiense sleeping sickness in Urambo District, Tanzania
Q28478935Should I get screened for sleeping sickness? A qualitative study in Kasai province, Democratic Republic of Congo
Q38759672Social stigma towards neglected tropical diseases: a systematic review
Q52602671The impact of passive case detection on the transmission dynamics of gambiense Human African Trypanosomiasis.
Q47186581The socio-economic burden of human African trypanosomiasis and the coping strategies of households in the South Western Kenya foci
Q36551049Treatment options for second-stage gambiense human African trypanosomiasis

Search more.